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B1 is a member of a conserved protein family that
localizes to growing microtubule plus ends. EB1 pro-
teins also recruit cell polarity and signaling molecules
to microtubule tips. However, the mechanism by which EB1
recognizes cargo is unknown. Here, we have deﬁned a
repeat sequence in adenomatous polyposis coli (APC) that
binds to EB1’s COOH-terminal domain and identiﬁed a
similar sequence in members of the microtubule actin
cross-linking factor (MACF) family of spectraplakins.
We show that MACFs directly bind EB1 and exhibit EB1-
E
 
dependent plus end tracking in vivo. To understand how
EB1 recognizes APC and MACFs, we solved the crystal
structure of the EB1 COOH-terminal domain. The structure
reveals a novel homodimeric fold comprised of a coiled
coil and four-helix bundle motif. Mutational analysis
reveals that the cargo binding site for MACFs maps to a
cluster of conserved residues at the junction between the
coiled coil and four-helix bundle. These results provide a
structural understanding of how EB1 binds two regulators
of microtubule-based cell polarity.
 
Introduction
 
The microtubule cytoskeleton, whose minus ends in most cells
are located near the centrosome and plus ends extend toward
the cell periphery, is involved in the long range transport of
membrane organelles, mRNAs, protein complexes, and chro-
mosomes (Karcher et al., 2002). To achieve these functions,
microtubules serve as tracks for motor proteins that move
along the microtubule surface. A second and more recently
discovered type of intracellular transport is driven by the inherent
polymerization of tubulin at the microtubule plus end (Desai
and Mitchison, 1997). Several “plus end–tracking” proteins
have been described that continually bind to the growing plus
end of the microtubule and then dissociate, after a temporal
delay, from the microtubule shaft. By tracking along the tips of
microtubules, plus end–tracking proteins can be delivered to
the cell cortex. Cortical polarity factors also can bind to plus
end–tracking proteins, leading to the capture and selective
stabilization of the microtubule and communication with the
actin network (Korinek et al., 2000; L. Lee et al., 2000; Miller
et al., 2000). Such interactions between microtubule plus ends
and the cortex have been shown to be important for orienting
the microtubule network, which can polarize the cell for migration
or rotate the mitotic spindle during asymmetric cell divisions
(L. Lee et al., 2000; Lu et al., 2001; Etienne-Manneville and
Hall, 2003).
The two best characterized microtubule plus end binding
proteins are Clip-170 and EB1, which are conserved from
yeast to humans. The Clip-170 protein family is characterized
by NH
 
2
 
-terminal microtubule-interacting Cap-Gly domains
and a COOH-terminal region that recruits various cargos, in-
cluding the dynein–dynactin complex (Lansbergen et al.,
2004), and vesicles (Pierre et al., 1992). EB1 members have a
similar bipartite composition: the NH
 
2
 
-terminal domain medi-
ates microtubule plus end localization and a COOH-terminal
cargo binding domain that captures cell polarity determinants.
In 
 
Saccharomyces cerevisiae
 
, an EB1 homologue, Bim1p,
links microtubules to the cell cortex by interacting with the
polarity determinant Kar9p (Korinek et al., 2000; L. Lee et al.,
2000; Miller et al., 2000). In mammalian cells, the tumor
suppressor adenomatous polyposis coli (APC) protein plays a
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functionally homologous role (Su et al., 1995; Lu et al., 2001).
In addition to its role as a scaffold for the regulated degradation
of 
 
 
 
-catenin (Su et al., 1993), APC plays a role in microtubule-
based cell polarity (Rubinfeld et al., 1993; Lu et al., 2001). EB1
was originally identified as an APC binding protein, and this
interaction appears to be important for the later pathway (Su et
al., 1995; Lu et al., 2001). Several signaling pathways establish
polarity via EB1–APC recruitment including: (a) the sequential
activation of CDC42, Par6-associated atypical PKC, and GSK-
3
 
 
 
, which in turn localizes APC to the leading edge of astro-
cytes in a wounded monolayer (Etienne-Manneville and Hall,
2003; Kodama et al., 2003), (b) an NGF-induced axon growth
pathway (Zhou et al., 2004), (c) the Rho-activated mDia re-
cruitment of EB1 and APC in fibroblast cell migration (Wen et
al., 2004), and (d) a microtubule actin cross-linking factor
(MACF)–based recruitment of EB1 and APC to the muscle–
tendon junction in 
 
Drosophila melanogaster 
 
(Subramanian et
al., 2003). The EB1–APC interaction also is likely to be critical
for tumorigenesis/metastasis of intestinal epithelial, probably
through a loss of the normal polarity of the epithelia. The ma-
jority of APC mutations in human tumors involve deletion of
its EB1 binding domain (Powell et al., 1992; Su et al., 1993).
Previous biochemical studies have shown that the
COOH-terminal half of EB1 is sufficient for binding APC
(Askham et al., 2000; Bu and Su, 2003). Likewise, in yeast, the
corresponding region of Bim1p is used for Kar9p binding
(Miller et al., 2000). Overexpression of the EB1 COOH-termi-
nal domain also produced a dominant-negative phenotype in
cell polarization (Wen et al., 2004; Zhou et al., 2004). Collec-
tively, these studies establish EB1’s COOH terminus as a cargo
binding domain and a key determinant in search and capture
processes. However, the structural mechanism by which EB1
recognizes its cargo is unknown. Here, we have identified a re-
peat motif in APC that binds EB1 and found a similar motif in
the MACF family of spectraplakins, which allows these pro-
teins to bind to EB1 and track along microtubule plus ends in
vivo. We also solved the X-ray crystal structure of EB1’s cargo
binding domain and mapped the residues involved in MACF
binding by alanine scanning mutagenesis. These results pro-
vide a structural understanding of how EB1 recruits cargo to
the microtubule plus end.
 
Results
 
The EB1 COOH-terminal domain binds to 
a repeat motif in APC and MACFs
 
We first set out to define a minimal domain in human APC that
interacts with the human EB1 COOH-terminal domain. Previ-
ous studies using a two-hybrid screen and in vitro binding re-
vealed that the COOH-terminal 170 amino acids of APC can in-
teract with EB1 (Su et al., 1995; Askham et al., 2000). To gain
further insight on this APC region, we performed a detailed se-
quence analysis and identified four cryptic repeats of 21–25
amino acids (designated repeats I–IV), which are character-
ized by conserved prolines, serines, threonines, and positively
charged residues (Fig. 1 B). The highest degree of homology
was observed between repeats III and IV, which displayed 44%
amino acid identity and 52% homology. To determine if all or a
subset of these repeats constituted functional EB1 binding sites,
we constructed several APC-GFP fusion constructs representing
all contiguous combinations of the repeats and tested them for
binding to a GST-EB1
 
185-255
 
 column. APC constructs containing
repeats III and IV were retained on this column, but proteins
lacking the repeat III–IV pair failed to bind, as did the single III
or IV repeat proteins (Fig. 1 A). Mapping the EB1 binding site
to repeats III and IV (APC
 
2782-2831
 
) corroborates data from Bu
and Su (2003), who delineated an overlapping APC region for
EB1 binding (APC
 
2781-2820
 
). The minimal construct defined by
Figure 1. Delineation of the EB1–APC and EB1–MACF2 interaction regions. (A) Summary of EB1 binding assays. APC constructs are delineated in green,
MACF2 in blue. (B) Alignment of APC repeat regions I–IV. Identity is indicated in red, homology in orange. (C) Alignment of the EB1 binding motif of
human APC, human MACF2, murine MACF2, and Drosophila Shot, with conservation colored as in B. Asterisks denote tentative PKA (green) and CDC2
(blue) phosphorylation sites. (D) Coomassie-stained polyacrylamide gel showing MACF21595-1637 retention on a GST-EB1185-255 column. (E) GFP-APC2744-2834
and MACF21596-1637 compete for binding to GST-EB1185-255. 10  l GST-EB1185-255–bound glutathione Sepharose beads were preincubated with 0, 138,
225, and 550 nmol MACF21595-1637 for 30 min before incubation with 550 nmol GFP-APC2744-2842 for an additional hour. Resin was washed three times
in batch with wash buffer, and the amount of bound GFP-APC2744-2843 was analyzed by Coomassie-stained SDS-PAGE. 
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Bu and Su (2003) compromises the COOH-terminal 11 amino
acids of repeat IV, which, although retaining EB1 binding, may
result in decreased affinity. Additional support for EB1 binding
to this region is derived from phosphorylation and phosphomi-
metic mutation studies of residues within repeats III and IV. In
these studies, modulation of the CDC2 and PKA phosphorylation
sites (Fig. 1 C) reduced or ablated EB1 binding (Askham et al.,
2000; Nakamura et al., 2001; Bu and Su, 2003).
We investigated whether or not any other proteins have
repeat motifs homologous to those in APC that bind EB1. After
performing a BLAST search (Altschul et al., 1990) using APC
repeats III and IV, we identified a similar sequence (38% iden-
tity and 57% homology; Fig. 1 C) in the human and mouse
spectraplakin family member MACF2 (Sun et al., 2001). Previ-
ous work has shown that ACF7 (a mouse MACF) binds to the
plus ends of microtubules in mammalian tissue culture cells,
but an interaction with EB1 was not investigated (Kodama et
al., 2003). Like APC, MACFs are large, multidomain proteins
characterized by tandem, NH
 
2
 
-terminal calponin homology do-
mains that mediate binding to actin filaments, a plakin domain,
a central rod-like region composed of dystrophin-like spec-
trin repeats that typically spans 1,000–4,000 residues, and a
COOH-terminal region comprised of two EF-hand motifs,
a GAS2/GAR2 domain that confers microtubule association
(Sun et al., 2001), a series of quadruplet repeats typified by the
sequence GSRA, and a final 50–100 residues of unknown func-
tion (Leung et al., 1999). The APC-like repeat motifs that we
identified are found in this very COOH-terminal region of hu-
man MACF2, the murine MACF2, and the 
 
Drosophila
 
 MACF
Shot (also known as Shortstop or Kakapo). Unlike APC, which
has four repeat motifs, the MACFs only have two repeats that
are more similar to APC repeats III and IV than to I and II.
We tested whether or not the dual MACF repeat is indeed
capable of binding to EB1. We purified the human MACF2 re-
peat (MACF2
 
1595-1637
 
) and tested its binding to GST fusions of
full-length EB1 or its COOH-terminal (EB1
 
185-255
 
) domain pre-
bound to glutathione-Sepharose. Both full-length GST-EB1 (not
depicted) and GST-EB1
 
185-255
 
 retained the MACF2
 
1595-1637
 
 pep-
tide, whereas GST alone did not (Fig. 1 D). Thus, like APC, the
MACF2 repeat motif is capable of specifically binding to the
EB1 COOH-terminal domain in vitro. Additionally, competition
experiments using GST-EB1
 
185-255
 
 prebound to glutathione-Seph-
arose, fixed levels of GFP-APC
 
2744-2843
 
, and increasing level of
MACF2
 
1595-1637
 
 revealed that MACF2 could compete with APC
for binding to the EB1 COOH-terminal domain (Fig. 1 E).
 
DmEB1 associates with the 
 
Drosophila
 
 
spectraplakin Shot
 
Next, we wished to determine if the MACF interaction with
EB1 also occurs in vivo. We pursued this question using 
 
Dro-
sophila
 
 S2 cells because DmEB1 can be very efficiently de-
pleted in these cells by RNAi (Rogers et al., 2002). The solitary
MACF homologue in 
 
Drosophila
 
 is Shot, which is expressed
as many different isoforms. Shot was initially isolated in a
screen for proteins involved in integrin-mediated adhesion and
has subsequently been found to play a critical role during axon
extension as a cytoskeletal cross-linker (Gregory and Brown,
1998; Lee and Kolodziej, 2002). Additional work demon-
strated that Shot recruits DmEB1 and APC1 to the muscle–ten-
don junction to promote microtubule assembly, but it was not
investigated whether the Shot–DmEB1 association was direct
or indirect (Subramanian et al., 2003). In S2 cells, DmEB1 lo-
calizes to the plus ends of microtubules in a “comet-tail” pat-
tern throughout the cell cycle as well as to centrosomes and
spindle poles (Rogers et al., 2002). When cells were double
stained for DmEB1 and Shot, we found that the distribution of
the proteins overlapped but were not identical (Fig. 2, A–C).
Shot antibodies labeled microtubules along their entire length
but were enriched at their tips and also stained small punctae
throughout the cell. However, close examination of the micro-
tubules with double staining of Shot and DmEB1 revealed a
terminal “cap” of DmEB1 (
 
 
 
1 
 
 
 
m long) that lacked Shot fol-
lowed by a region of overlap of both proteins in 106 out of 120
microtubules examined (Fig. 1 C). These results indicate that
DmEB1 and Shot colocalize on microtubules but also maintain
individual zones of localization, which is similar to observa-
tions made for EB1 and APC in mammalian cells (Juwana et
al., 1999; Askham et al., 2000; Mimori-Kiyosue et al., 2000;
Nakagawa et al., 2000; Barth et al., 2002).
We expressed Shot (B isoform) fused to a COOH-termi-
nal GFP and observed its localization in living S2 cells using
spinning disk confocal microscopy. As predicted by immuno-
fluorescence, Shot-GFP associated with microtubules, but ex-
hibited two types of dynamic behaviors. On dynamic microtu-
bules, Shot-GFP tracked along with growing microtubule plus
ends at a velocity of 4.0 
 
 
 
 0.8 
 
 
 
m/min (the rate of microtu-
bule elongation in GFP-tubulin–expressing cells [Rogers et al.,
2002]). This tip-associated Shot-GFP exhibited a comet-tail
distribution, but unlike the short (
 
 
 
2 
 
 
 
m) comet tails of EB1,
the length of the microtubule decorated by Shot-GFP was often
 
 
 
5 
 
 
 
m (Video 1, available at http://www.jcb.org/cgi/content/
full/jcb.200410114/DC1). Association of Shot-GFP with mi-
crotubule plus ends was also observed in mitosis, particularly
on the halo of astral microtubules that emanated toward the
cortex. A second population of microtubules associated with
Shot-GFP along their length and were stable over extended
(
 
 
 
20 min) periods of observation, exhibiting neither growth
nor shrinkage typified by dynamic instability. Such highly sta-
ble microtubules were never observed in S2 cells expressing
GFP-tubulin alone (unpublished data). Thus, overexpression of
Shot-GFP compared with wild-type cells is likely to account
for this suppression of microtubule dynamics. In support of this
idea, when Shot-GFP was expressed at very high levels (2 d af-
ter transfection), exaggerated microtubule bundling and a com-
plete suppression of microtubule dynamics was observed (Lee
and Kolodziej, 2002; unpublished data).
We tested if EB1 was required for the plus end tracking
of Shot-GFP by depleting EB1 (
 
 
 
1% of wild type) using
RNAi (Rogers et al., 2002). RNAi-treated cells expressing
GFP-tubulin under a constitutive actin promoter were double
labeled for Shot and DmEB1 to identify unambiguously the
DmEB1-depleted cells. Control cells showed colocalization of
Shot at microtubule plus ends. In EB1 RNAi-treated cells, Shot
never associated with microtubules (
 
n
 
 
 
  
 
900 cells), either at 
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their tips or along their length (Fig. 2 E). Instead, Shot immu-
nofluorescence staining revealed a punctuate pattern with no
discernible microtubule association. In contrast, RNAi deple-
tion of D-Clip-190 (another plus end–tracking protein) did not
alter Shot’s microtubule localization (unpublished data). These
results indicate that association of Shot with microtubules re-
quires DmEB1; however, albeit less likely, it cannot be ruled
out that Shot mislocalization in DmEB1 RNAi-treated cells
could be due to the relative undynamic nature of microtubules
after DmEB1 depletion (Rogers et al., 2002).
 
The crystal structure of EB1’s COOH-
terminal cargo binding domain
 
To better understand the structural basis of cargo recognition
by EB1, we crystallized its conserved COOH-terminal cargo
binding domain (residues 185–255). Two crystal forms were
obtained: P2
 
1
 
 (two molecules per asymmetric unit, 2.0 Å
 
 
 
reso-
lution) and C222
 
1
 
 (one molecule per asymmetric unit, 1.8 Å
resolution) (see Materials and methods). Phase information
was obtained for both crystal forms by multiwavelength anom-
alous diffraction (MAD) using the selenomethionine (SeMet)-
derivatized construct V243M, in which a methionine was in-
corporated at the homologous site of a methionine in the EB1
homologue RP1 (Fig. 3 D) to enhance MAD phasing power.
The refinement of the structures yielded the following statis-
tics: P2
 
1
 
 crystal form, R 
 
 
 
 21.9, R
 
free
 
 
 
 
 
 25.1; C222
 
1
 
 crystal
form, R 
 
 
 
 22.1, R
 
free
 
 
 
 
 
 25.9. Further details on the diffraction
data, phasing, refinement, and model statistics are presented in
Table I. Coordinates have been deposited in the Protein Data
Bank under accession codes 1YIG (P2
 
1
 
 crystal form) and 1YIB
(C222
 
1
 
 crystal form).
The crystal structure of the EB1 COOH-terminal domain
reveals a unique homodimeric structure formed by a coiled coil
that folds back at the COOH-terminal region to form a four-
helix bundle (Fig. 3 A). A search of structural domains in the Pro-
tein Data Bank failed to identify a similar homodimeric fold.
The homodimer engages both protomers in the P2
 
1
 
 asymmetric
unit, whereas a crystallographic two-fold in the C222
 
1
 
 form de-
lineates the molecule’s endogenous symmetry. Entirely helical
in structure, the COOH-terminal domain is defined by helices
 
 
 
A and 
 
 
 
A
 
 
 
 (where 
 
 
 
 refers to the homodimeric mate) that span
residues 190–230, 
 
 
 
B and 
 
 
 
B
 
 
 
 that span residues 238–248, and
a solitary helix 
 
 
 
C that spans residues 251–254 found in only
one protomer of the P2
 
1
 
 crystal form. Helices 
 
 
 
A and 
 
 
 
A
 
 
 
 en-
gage in a coiled coil over residues 190–218, burying conserved
hydrophobic side chains and the aliphatic region of a conserved
lysine (K204). No density was observed for residues 185–189
in either crystal form, thus delineating the start of the dimeriza-
tion domain at residue 190. The remaining portion of 
 
 
 
A and
 
 
 
A
 
 
 
 cooperate with 
 
 
 
B and 
 
 
 
B
 
 
 
 to form a four-helix bundle
that contributes 1,540 Å
 
2
 
 to the total 3,340 Å
 
2
 
 of buried surface
area formed in homodimerization. Superimposition of the P2
 
1
 
and C222
 
1
 
 crystal forms along 
 
 
 
A reveals a plasticity in the rel-
ative twist of the coiled coil and four-helix bundle (Fig. 3 C).
Differences in the organization of the loop bridging helices 
 
 
 
A
and 
 
 
 
B are apparent, correlating with this region’s low homol-
Figure 2. Shot is recruited to microtubule tips by DmEB1. (A) Colocalization of DmEB1 (green) and Shot (red) on microtubule tips in Drosophila S2 cells.
(B) Enlarged view of the yellow boxed region outlined in A detailing microtubule tip localization. Individual channels and the resulting merged image are
indicated. The distribution of DmEB1 (green) and Shot (red) on individual microtubule tips designated by numbers in B are represented in C normalized
against individual maximum intensity along the microtubule axis with a minus and plus denoting the polarity of the microtubule tip. (D) Control S2 cells
expressing GFP-tubulin (green) and immunostained for Shot (red); colocalization of Shot at microtubule tips can be seen. (E) After DmEB1 RNAi treatment,
Shot (red) is diffusely localized and no longer stains at microtubules tips or along the length of the microtubule, as shown in this representative S2 cell
expressing GFP-tubulin (green). 900 cells were analyzed in total. Bars: (A) 5  m; (C) 1  m; (D and E) 10  m. 
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ogy and exemplified by a five amino acid insert located within
the corresponding region of 
 
Schizosaccharomyces pombe
 
 Mal3
(Fig. 3 D). The final helix, 
 
 
 
C is ordered in one protomer of the
P2
 
1
 
 crystal form, most likely due to crystal packing contacts.
Due to its disorder in the C222
 
1
 
 crystal form and in one pro-
tomer of the P2
 
1
 
 crystal form, we suspect 
 
 
 
C is flexible in solu-
tion, but due to its proximity to the MACF binding region de-
scribed in the following section, it may transit to an ordered
state upon cargo binding.
To elucidate tentative sites responsible for cargo inter-
action, we examined the spatial positions of conserved resi-
dues (defined by invariance, 85% identity and 85% homology)
across 13 representative EB1 family members from yeast to
vertebrates (Fig. 3 D). Under this classification system, con-
served residues within the NH
 
2
 
-terminal region of the coiled
coil (
 
 
 
A and 
 
 
 
A
 
 ) are predominantly buried and constitute the
hydrophobic core of the coiled coil (Figs. 3 D and 4 B). The
highest near-continuous stretch of conservation occurs along
the second half of  A, spanning residues 211–229 at the coiled
coil–four-helix bundle junction (Fig. 3 D). Amidst this stretch
of conservation are the invariant residues F216, Y217, and
F218 (Fig. 3, B and D) that form symmetrical, stacked arrays of
solvent-exposed hydrophobic side chains that flank each side
of the coiled coil. The register of the coiled coil dictates that the
spatial FYF  motif be comprised of F216 and Y217 from one
chain and F218  from the homodimeric mate (Fig. 3 B). Addi-
tional conservation at this junction is provided by two solvent-
exposed residues of the  B helix: I245 and Y247. This con-
served surface is characterized by both a hydrophobic character
and a net negative charge contributed by the acidic residues
E211, E213, D215, and E225 (Fig. 4 D). The composite archi-
tecture of a conserved solvent-exposed region with hydropho-
bic and charged character implicated this zone as the tentative
cargo binding site.
Conserved residues constitute the APC-
MACF binding site
To identify the residues in EB1 that contact cargo, we devel-
oped a surface plasmon resonance binding assay. We prepared
a construct of the MACF21595-1637 EB1 binding region with an
Figure 3. Crystal structure of the EB1 COOH-
terminal domain. (A) Ribbons diagram of the
homodimeric EB1 COOH-terminal domain
( A, blue;  B, pink;  C, green). (B) Experi-
mental electron density map of the C2221
crystal form calculated to 2.0 Å, contoured at
1.0  , and superimposed over the conserved
FYF  motif located at the junction of the coiled
coil–four-helix bundle junction. The view is
directed down the two-fold axis of the coiled
coil. (C) Comparison of the P21 and C2221
crystal structures after a least squares fit over
 A. (D) Alignment of 13 EB1 family members
from diverse species. Secondary structure is
indicated in colors corresponding to those in
A. The regions constituting the coiled coil and
four-helix bundle are indicated. Invariance is
indicated in dark green, 85% identity in light
green, and 85% homology in yellow. Side
chain solvent accessibility is indicated in the
bar graph below. Residues involved in homo-
dimer contacts are indicated with red asterisks.
Residues mutated to alanine, phenylalanine, or
methionine for binding studies and phasing
purposes are indicated above the alignment.JCB • VOLUME 168 • NUMBER 4 • 2005 592
NH2-terminal His-tag and a COOH-terminal motif (GGGLN-
DIFEAQKIEWHE) that becomes biotinylated at the lysine res-
idue during expression in Escherichia coli (Beckett et al.,
1999). MACF21595-1637 peptide was immobilized on a streptavi-
din sensor chip, increasing concentrations of NH2-terminally
His-tagged full-length EB1 were injected, and binding was de-
tected by the increased mass density at the sensor chip surface.
Full-length EB1, rather than EB1185-255, was used to maximize
the binding signal. Analysis revealed that the on-rate and maxi-
mal signal increased with increasing concentrations of EB1;
however, a very slow off-rate was observed, which is most
likely due to bivalent complex formations of two peptides with
EB1, which retarded dissociation from the surface. The best fit
of these curves was also achieved assuming a bivalent binding
reaction (unpublished data). However, the very slow off-rate
rate made it difficult to accurately determine kd1 and the equi-
librium binding constant.
To test the individual binding contribution of residues
within the 211–229 conserved span, we prepared single alanine
mutations, with the exception of Y217 for which both alanine
(Y217A) and phenylalanine (Y217F) mutants were generated.
Mutant EB1 proteins were analyzed for MACF21595-1637 binding
using the surface plasmon resonance assay at a fixed concen-
tration of 2.5  M and compared with the behavior of wild-type
EB1 at the same concentration (Fig. 5 B). A spectrum of associ-
ation rates was obtained for the various mutants and classified
according to effect (altered association, yellow; no binding,
red). Only one mutant of a nonconserved glycine (G219A)
displayed wild-type association kinetics (Fig. 3 D). Several
alanine mutations of charged/polar residues (E211A, K212A,
E213A, R214A, D215A, R222A, N223A, and Q229A) dis-
played altered association. No binding was obtained for the
F216A, Y217A, F218A, K220A, I224A, and E225A mutants.
All mutants that showed no MACF2 binding were analyzed by
gel filtration to determine if homodimerization had been com-
promised. All mutants eluted at the position of a homodimer at
the concentrations used for the binding study (not depicted),
except for I224A, which eluted at the position of a monomer
(Fig. 5 C). I224 is the only residue mutated that is completely
buried, situated at the core of the four-helix bundle. These re-
Table I. Crystallographic data, phasing, and refinement
Beamline: Advanced Light Source 8.3.1
Space group: P21 Cell dimensions: a 33.1 Å, b 37.3 Å, c 56.9 Å,   90 ,   106.1 ,   90  Phasing Power
b
Data Statistics: dmin (Å) Completeness (%) I/  Rsym (%)
a  Friedel mate  Friedel mate
SeMet  1 (0.97964 Å) 2.00 92.8 (83.8) 25.2 (6.4) 3.4 (13.4) 0.27 (0.17) 0.81 (0.54)
SeMet  2 (0.97979 Å) 2.00 93.6 (80.8) 23.1 (2.4) 3.8 (31.9) 2.05 (0.71) 2.05 (0.76)
SeMet  3 (1.12713 Å) 2.00 82.3 (40.4) 25.4 (6.1) 3.0 (13.3) Reference 0.35 (0.17)
Figure of merit
c: centrics: 0.81 (0.59) acentrics: 0.57 (0.25)
Refinement: (50–2.0 Å)
R Value
d: 21.9 (20.3)
Rfree
e: 25.1 (23.3)
Rmsd bond lengths (Å): 0.006
Rmsd bond angles ( ): 0.92
Mean B factor (min/max): 28.1 Å
2 (7.9 Å
2/65.7 Å
2)
Space group: C2221 Cell dimensions: a 33.1 Å, b 108.3 Å, c 37.2 Å,   90 ,   90 ,   90  Phasing Power
b
Data Statistics: dmin (Å) Completeness (%) I/  Rsym (%)
a  Friedel mate  Friedel mate
Native (1.12704 Å) 1.80 97.2 (87.1) 49.5 (11.2) 2.9 (14.1)
SeMet  1 (0.97973 Å) 2.00 92.1 (88.6) 20.9 (3.3) 4.8 (25.7) 1.74 (0.68) 1.89 (0.74)
SeMet  2 (0.99987 Å) 2.00 92.1 (83.9) 22.8 (3.8) 4.3 (21.3) Reference 0.29 (0.12)
Figure of merit
c: centrics: 0.70 (0.43) acentrics: 0.52 (0.20)
Refinement: (50–1.8 Å)
R value
d: 22.1 (24.9)
Rfree
e: 25.9 (28.8)
Rmsd bond lengths (Å): 0.004
Rmsd bond angles ( ): 0.82
Mean B factor (min/max): 24.2 Å
2 (12.0 Å
2/58.5 Å
2) 
Values in parentheses are for the highest resolution shells.
aRsym    h i|Ii(h)  I(h) |/  h iIi(h), where Ii(h) is the integrated intensity of the ith reflection with the Miller Index h, and  I(h)  is the average over Friedel and
symmetry equivalents. 
bMad phasing power is defined as [ |FD FN|
2 / P( )(||FNIe
i   Fh| FD|
2)d ]
1/2, where P( ) is the experimental phase probability distribution. FN are structure
factors at the designated reference wavelength and FD are structure factors of   or   Friedel mates at the other designated wavelength.  Fh is the difference in heavy
atom structure factors between two wavelengths. 
cFigure of merit is the weighted mean of the cosine of the deviation from  best.
dR value    (|Fobs| k|Fcalc|)/ |Fobs|.
eRfree is calculated using a 10% subset of the data that is removed randomly from the original data and excluded from refinement.DETERMINANTS OF EB1 CARGO RECRUITMENT • SLEP ET AL. 593
sults indicate that destabilization of the four-helix bundle com-
promises dimerization and that dimerization is essential for
MACF2 binding.
Mapping of mutant association results on the crystal
structure reveals a cluster of key binding residues along helix
 A, the dominant contributors to which are E211, D215, F216,
Y217, F218, R222, E225, and L226 (Fig. 6). The FYF  motif
provides a dramatic contribution to the binding interaction as
mutation of any of the three residues to alanine ablates binding.
In contrast, the Y217F mutation produces only a modest de-
crease in binding. Thus, the tyrosine’s hydrophobic Van der
Waals contacts, rather than hydrogen bonding by the hydroxyl,
makes a dominant contribution, either by contributing direct
binding energy to the protein–protein interface or by position-
ing the spatially flanking phenylalanine residues 216 and 218 ,
which in turn confer crucial contacts for MACF2 association.
Discussion
In this work, we have characterized the binding of EB1 to APC
and have identified a new EB1 binding partner, the spectra-
plakin MACF. We show using X-ray crystallography and
structure-function studies that a repeat region shared by APC
and MACF binds at an interface created by a four-helix bundle
motif in the COOH-terminal domain of EB1. We discuss the
implication of these findings for understanding how EB1 mole-
cules attract cargo binding partners to microtubule tips.
Diverse cell polarity determinants share 
a common EB1 binding motif
We have elucidated a motif shared by mammalian APC and sev-
eral mammalian spectraplakin MACFs. Although these two
families bear no apparent sequence homology outside the identi-
fied EB1 binding site, they do share a similar composite domain
architecture and cellular functions. Both proteins are extremely
large (1,000–5,000 amino acids) due to repeated domains in
their central regions ( -catenin and axin binding sites in APC
[Su et al., 1993; Rubinfeld et al., 1993] and dystrophin-like
spectrin repeats in MACFs [Leung et al., 1999]). Both proteins
also are characterized by microtubule binding motifs (Smith et
al., 1994; Deka et al., 1998; Sun et al., 2001) followed immedi-
ately after by the COOH-terminal EB1 recognition motif. In re-
cent studies, both APC and the spectraplakins ACF7 and Shot
have been shown to play roles in axon growth, cell polarity, and
migration (S. Lee et al., 2000; Lu et al., 2001; Etienne-Manne-
ville and Hall, 2003; Kodama et al., 2003; Subramanian et al.,
2003; Wen et al., 2004; Zhou et al., 2004). In these studies,
overexpression of the EB1 COOH-terminal domain resulted in a
dominant-negative disruption of polarity signaling, indicative
that an interaction with full-length EB1 is required for proper
Figure 4. A conserved region at the coiled
coil–four-helix bundle junction mediates cargo
interactions. (A) Domain architecture of the
EB1 heterodimer in ribbons format, with orien-
tation maintained in B, C, and D. Bottom
panel represents a 90  rotation about the y-axis.
(B) CPK representation of conserved residues:
dark green, invariant; light green, 85% identi-
cal; yellow, 85% homology (correlating to
residues and colors used in Fig. 3 D). (C) CPK
representation of mutations colored according
to the effect these mutations had on binding to
MACF21595-1637: yellow, altered binding; red,
no binding. (D) Surface potential from  15 to
 15 kBT (kB   Boltzmann’s constant, T is the
absolute temperature [K]) calculated in GRASP
(Nicholls et al., 1991).JCB • VOLUME 168 • NUMBER 4 • 2005 594
signal transduction/cytoskeletal stabilization by mammalian
APC and spectraplakins. GSK-3 , a kinase implicated in cell
polarity signal transduction pathways, also has been implicated
in the regulation of APC and MACFs (Etienne-Manneville and
Hall, 2003; Kodama et al., 2003; Zhou et al., 2004). It is possi-
ble that this kinase might, at least in part, control polarity by reg-
ulating EB1 interaction because in vitro studies have shown that
phosphorylation of APC abrogates binding to EB1 (Askham et
al., 2000; Nakamura et al., 2001; Bu and Su, 2003).
Interestingly, the two APC genes in Drosophila have
the  -catenin/axin binding domains, but lack the COOH-ter-
minal region in mammalian APC that contains the EB1 bind-
ing motif. To date, Drosophila APCs have not been observed
tracking along microtubule tips, although DmAPC2 has been
found to tether mitotic spindles to cortical actin (McCartney
et al., 2001). Furthermore, the spectraplakin interaction with
EB1 and microtubule tips appears to be widely conserved
in all metazoans. Previous work has implicated the MACF
Shot as an EB1-associated factor based on colocalization
and coimmunoprecipitation, but a direct interaction was not
shown (Subramanian et al., 2003). Here, we have definitively
demonstrated that the in vivo association of Shot with the tips
of microtubules is mediated by EB1. Thus, we speculate that
the spectraplakins may have represented the original meta-
zoan invention of a microtubule tracking, cell polarity factor
and that vertebrates subsequently incorporated this feature
into APC by duplication and gene integration. Consistent
with this idea, the EB1 binding motifs are more similar be-
tween vertebrate MACF and APC than they are between
MACFs from vertebrates and invertebrates.
In addition to the EB1 interaction, our localization studies
suggest other features about the mechanism by which spectra-
plakins and APC interact with microtubules. Shot colocalizes
only with the third of EB1 furthest from the microtubule plus
end (Fig. 2 C). This pattern, which is not observed for other
proteins such as RhoGEFs (Rogers et al., 2004), suggests that
Shot does not coassemble with EB1 on the growing end of the
microtubule but recognizes EB1 after a temporal delay, per-
haps also suggesting some additional mechanism of regulation.
The EB1 COOH-terminal domain is a 
structural scaffold for dimerization and 
cargo binding
Our X-ray crystallographic studies show that the conserved
EB1 COOH-terminal domain constitutes a unique coiled
coil–four-helix bundle motif that confers both dimerization
and cargo binding. Although EB1 and Bim1p were suggested
to have a coiled coil domain based on sequence analysis (Reh-
berg and Graf, 2002), this is the first physical evidence that
EB1 proteins are indeed dimers. Dimerization appears to rely
not only on the coiled coil but also on the four-helix bundle
motif, which provides nearly half of the buried surface area
formed in dimerization. Consistent with this idea, destabili-
zation of the four-helix bundle with the I224A mutation
abolishes dimerization.
We also used alanine scanning mutagenesis, based on
the crystal structure, to uncover a bivalent cargo binding site
Figure 5. Mutations within the coiled coil–four-helix bundle junction
abrogate binding to MACF21595-1637. (A) Surface plasmon resonance of
EB1 (FL) at various concentrations (solid lines) on a sensor chip with immo-
bilized MACF21595-1637. The resulting bivalent model is overlaid in dashed
lines with colors corresponding to experimental EB1 concentrations. (B)
Surface plasmon resonance of wild-type and mutant full-length EB1 con-
structs at 2.5  M on a sensor chip with immobilized MACF21595-1637.
Color coding at right designates the relative effect on the association of
the EB1 mutants with surface-bound peptide. Yellow, altered binding; red,
no binding. (C) Gel filtration analysis of EB1 full-length wild-type protein
and the EB1 I224A mutant.DETERMINANTS OF EB1 CARGO RECRUITMENT • SLEP ET AL. 595
in the EB1 COOH-terminal domain. Both subunits of the ho-
modimer appear to contribute residues to the cargo binding
site, which is also supported by the finding that abrogat-
ing dimerization prevents cargo binding. Although the EB1
COOH-terminal domain is highly negatively charged, many
of the key determinants in MACF2 binding are hydrophobic
and form a discrete exposed hydrophobic pocket in the center
of the domain. In comparison to the high conservation of
EB1’s COOH-terminal domain (from yeast to man), the re-
peat binding motifs found in APC and MACF2 are less well
conserved, especially if one compares Drosophila to human.
However, general features are the presence of several hydro-
phobic residues (mainly prolines) and a net positive charge.
We speculate that these prolines and other hydrophobics
dock into EB1’s hydrophobic pocket, whereas the charged
residues may augment the binding interaction by providing a
peripheral gasket.
The conservation of solvent-exposed residues in EB1’s
COOH-terminal domain extends from vertebrates down to the
yeast homologues Bim1 and Mal3. Kar9 is functionally homol-
ogous to APC and Shot in its general role of microtubule search
and capture (Miller et al., 2000); however, Kar9 does not have a
repeat motif architecture similar to APC/spectraplakins (Miller
and Rose, 1998). A weak segment of homology with hydropho-
bic character was reported between regions of Kar9 and the
EB1 binding motif (Bienz, 2001), but this site has not been ex-
perimentally confirmed. It will be interesting to compare and
contrast the molecular basis for the EB1–APC interaction and
the Bim1–Kar9 interaction to determine if a similar or unique
set of determinants govern these binding interactions.
Our results also help to explain previous mutagenesis re-
sults of EB1 that were performed before the availability of a
crystal structure. Wen et al. (2004) mutated conserved hydro-
philic residues within aa 211–229 in EB1 and found that the
mutations E211A/E213A, E211A/D215A, K220A/R222A, and
E211A/E213A/K220A/R222A inhibited EB1–APC interac-
tion in vitro and yielded supporting phenotypic behavior in
vivo in an mDia-mediated cell polarity pathway. Our results
predict the strongest effect for constructs containing the
K220A mutation and milder effects for the one with the E213A
mutation, which agrees with the observations by Wen et al.
(2004). This correlation between EB1 mutants binding to
MACF21595-1637 and APC also substantiates the likelihood of a
similar binding architecture between these two classes of pro-
teins and the EB1 COOH-terminal domain.
Implications of the EB1 COOH-terminal 
domain structure for other cargo binding 
interactions
Several EB1 family members exist in metazoan genomes (four
in Drosophila [Rogers et al., 2002] and three in humans [Su
and Qi, 2001]). Although the crystal structures reported in this
paper describe a homodimeric structure, we cannot rule out the
possibility that EB1 heterodimers exist and are used for diverse
cargo recognition. The length of the coiled coil domains and
the residues in the COOH-terminal domain that constitute the
hydrophobic core and mediate dimer contacts are highly con-
served across family members, especially within species (Fig.
3 D). Because each bivalent cargo binding site is formed from
residues contributed by each of the EB1 molecules, hetero-
dimers could confer complex, pair-wise cargo recognition
motifs. Thus, the possibility of whether or not heterodimers of
EB1 can form in vitro and within cells merits investigation.
The EB1 COOH-terminal domain also may contain cargo
binding sites other than the one that we defined for APC and
MACF at the coiled coil–four-helix bundle junction. Several
proteins, including the dynein–dynactin complex (Valetti et
al., 1999; Vaughan et al., 2002), Ncd (unpublished data; Gho-
shima, G, personal communication), the microtubule-desta-
bilizing kinesin Klp10A (Mennella et al., 2005), and RhoGEF2
(Rogers et al., 2004), have been reported to track along micro-
tubule tips and associate with EB1. However, only in the cases
of the p150Glued dynactin subunit (Askham et al., 2002; Tir-
nauer et al., 2002; Bu and Su, 2003; Wen et al., 2004) and
Klp10A (Mennella et al., 2005) has a direct interaction with
EB1 been shown. In the case of p150Glued, deletion studies
have suggested that p150Glued and APC use overlapping
yet unique binding sites on EB1’s COOH-terminal domain
(Askham et al., 2002; Bu and Su, 2003; Wen et al., 2004). The
p150Glued binding site maps to EB1’s coiled-coil–four-helix
bundle but also requires EB1’s COOH terminus (13 residues
not included in our crystallization construct). Thus, it is possible
that EB1 contains multiple cargo binding sites, some of which
might be independent and others which might be mutually
exclusive. The crystal structure reported here should provide a
valuable tool for probing these future questions concerning
EB1–cargo interactions.
Figure 6. Key hydrophobic and charged residues define a conserved
MACF21595-1637 binding site. Residues mutated in the plasmon resonance
study and their relative effect on the binding to the MACF21595-1637 peptide
are shown, superimposed on a ribbons model of the COOH-terminal
domain. A reference point is indicated in the top left. Residues are color
coded according to the effect on MACF21595-1637 peptide binding: yellow,
altered binding; red, no binding.JCB • VOLUME 168 • NUMBER 4 • 2005 596
Materials and methods
DNA manipulation, protein preparation, and immunoblots
Human cDNA encoding EB1 was obtained from the American Type Culture
Collection and subcloned into the E. coli expression vectors pGEX-6P2
(Amersham Biosciences) and pET28a (Novagen). The EB1 conserved
NH2-terminal domain (residues 12–133) and the conserved COOH-terminal
domain (residues 185–255) were independently subcloned into pGEX-6P2.
A COOH-terminal mutant, V243M, in EB1185-255 was created using the
PCR sewing method and inserted into pGEX-6P2. Site-directed mutagenesis
was conducted on the full-length EB1-pET28a construct using the Quick-
change method (Stratagene) to create the point mutants described in Figs.
4–6. APC constructs (residues 2744–2843, 2694–2843, 2739–2831,
2739–2806, 2739–2781, 2739–2759, 2760–2831, 2760–2806,
2760–2781, 2782–2831, 2782–2806, and 2807–2831) and EB1 con-
structs (full length and residues 185–255) were subcloned into a modified
pET15 (Novagen) vector to yield an NH2-terminal hepta-histidine tag fol-
lowed by GFP and the specified region of APC. APC cDNA was provided
by K. Kinzler and B. Vogelstein (Johns Hopkins University, Baltimore, MD).
Residues 1595–1637 of KIAA0728 (human MACF2) were synthesized at
the DNA level using optimal E. coli codon usage and subcloned into
pGEX-6P2. A modified version of MACF21595-1637 (pGEX-6P2) was created
using the PCR method to introduce a hexa-histidine tag NH2-terminal to
MACF21595-1637 and a biotinylation tag (GGGLNDIFEAQKIEWHE; for in
vivo biotinylation [Beckett et al., 1999]) at the COOH terminus.
All aforementioned constructs were transformed into BL21 (DE3)
E. coli for recombinant expression (excluding a SeMet growth of the
pGEX-6P2 EB1185-255 V243M mutant in which the construct was trans-
formed into B834 E. coli and grown as previously described [Leahy et
al., 1994]). Cultures were grown in 2  YT at 37 C to an optical density
at 600 nm of 0.6, temperature was decreased to 20 C, and IPTG was
added to a final concentration of 100  M. Cultures were induced for
16 h, harvested, and frozen at  20 C. Bacterial pellets of pGEX-6P2 EB1
constructs were resuspended in lysis buffer (25 mM Tris, pH 8.0, 200
mM NaCl, and 0.1%  -mercaptoethanol [ -ME]) and lysed using a mi-
crofluidizer (Microfluidics, Inc.). 2 mM PMSF was added, and the lysate
was clarified by centrifugation at 36,000 g for 45 min. Supernatant was
incubated with glutathione-Sepharose beads for 30 min at 4 C with rota-
tion. Resin was collected by centrifugation at 200 g for 10 min, loaded
onto a column, washed with 100 column volumes of lysis buffer, and then
protein was applied to the column to test for retention. Additional purifi-
cation of GST-EB1185-255 and GST-EB1185-255 V243M proceeded as fol-
lows. GST fusion protein was step eluted using 5 column volumes of lysis
buffer supplemented with 50 mM glutathione, pH 8.0. 30  l of Pre-
Scission protease (Amersham Biosciences; 2 mg/ml stock) was added
and incubated at 4 C for 12 h, which yielded near complete cleavage.
Cleaved fusion protein was concentrated in a Centriprep YM-3 (Milli-
pore) and diluted 100-fold into 25 mM Tris, pH 7.0, 0.1%  -ME, and
loaded onto SP Sepharose Fast Flow resin (Amersham Biosciences) and
eluted using a NaCl gradient of 0–1 M over 20 column volumes. Protein
fractions were pooled, concentrated in a Centriprep YM-3, and ex-
changed into storage buffer (10 mM Tris, pH 7.0, 25 mM NaCl, and
0.1%  -ME). All buffers used for the EB1185-255 V243M SeMet purification
also contained 5 mM methionine as a supplemental reducing agent.
Additional purification of GST-H6-MACF21595-1637-Biotinylation Tag en-
tailed PreScission protease cleavage, followed by binding to Ni
2 -nitrilo-
triacetic acid resin, washing in 25 mM Tris, pH 8.0, 15 mM imidazole,
300 mM NaCl, 0.1%  -ME, and step elution using washing buffer sup-
plemented with 285 mM imidazole. Eluted protein was concentrated and
exchanged into 10 mM Tris, pH 8.0, 150 mM NaCl, and 0.1%  -ME using
a Centriprep YM-3. All H7-GFP fusion proteins were purified as follows.
Bacterial cell pellets were thawed and resuspended in lysis buffer (25 mM
Tris, pH 8.0, 300 mM NaCl, 15 mM imidazole, and 0.1%  -ME), lysed
in a microfluidizer, supplemented with 2 mM PMSF, and centrifuged at
36,000 g for 45 min at 4 C. Supernatant was incubated in batch with
Ni
2 -nitrilotriacetic acid resin for 30 min at 4 C. Resin was harvested by
centrifugation at 200 g at 4 C, loaded into a column, and washed with
100 column volumes of lysis buffer. EB1 mutants were washed with 10
column volumes of lysis buffer supplemented with 15 mM imidazole, and
step eluted with lysis buffer supplemented with 285 mM imidazole. All
other H7-GFP fusion proteins were eluted using a gradient of 15–300 mM
imidazole over 20 column volumes. Eluted H7-GFP fusion proteins were
concentrated in a Centriprep YM-3, exchanged into 10 mM Tris, pH 8.0,
150 mM NaCl, and 0.1%  -ME, frozen in liquid nitrogen, and main-
tained at  80 C until used.
Drosophila tissue culture and immunofluorescence
Drosophila S2 cells were cultured, treated for RNAi, and processed for im-
munofluorescence as described previously (Rogers et al., 2002). Primary
antibodies used for these studies were murine monoclonal anti-Shot
(raised using the antigen Shot L(A) 1454–1909, which was prepared as a
PreScission protease cleavage product from a GST fusion [Amersham Bio-
sciences]), rabbit anti–Clip-190 (Lantz and Miller, 1998), and rabbit anti-
DmEB1 (Rogers et al., 2002). Secondary antibodies (TMR anti-rabbit, Cy5
anti–mouse, Cy2 anti–rabbit, and Cy3 anti–guinea pig; Jackson Immu-
noResearch Laboratories) were used at a dilution of 1:300.
Time-lapse observation of Shot-GFP in living cells was performed by
cotransfection of S2 cells with pUAS-Shot (L) B-GFP (Lee and Kolodziej,
2002) and pMT-GAL4 (Rogers et al., 2004) using the Cellfectin transfection
reagent (Invitrogen) following the manufacturer’s protocols. GAL4-mediated
Shot-GFP was induced with a 2-h induction using 1  M copper sulfate and
imaged using a spinning disk confocal microscope (Solamere Technology
Group) mounted on an Axiovert 200 (Carl Zeiss MicroImaging, Inc.)
equipped with an XR/Mega10 intensified charge coupled device camera
(Stanford Photonics) driven by QED In Vivo software (QED Imaging).
Crystallization, data collection, data processing, model building, and 
refinement
The EB1 COOH-terminal domain (residues 185–255) was crystallized us-
ing the hanging drop vapor diffusion method at 20 C. 2  l EB1 COOH-ter-
minal domain at 15 mg/ml was added to 2  l of mother liquor containing
22% PEG 200, 100 mM ammonium acetate, pH 4.6, and equilibrated
over 1 ml of the mother liquor. Native crystals were crushed and used to
streak-seed crystals of the EB1 COOH-terminal domain mutant V243M
SeMet. The V243M SeMet protein crystallized in the space group P21 with
two molecules in the asymmetric unit. Attempts to cocrystallize a complex
of EB1185-255 with MACF21595-1637 using similar crystallization conditions
yielded native and SeMet crystals of EB1 (without MACF21595-1637 present)
in the space group C2221 with one molecule in the asymmetric unit. Crys-
tals were transferred to Paratone-N and flash frozen in liquid nitrogen.
Diffraction data were measured at the Lawrence Berkeley National
Laboratory Advanced Light Source beamline 8.3.1 using an ADSC 210
charge coupled device detector and maintained at 100 K using a nitro-
gen cryo stream. Data were processed and scaled using DENZO and
SCALEPACK (Otwinowski, 1993). Heavy atom searches were performed
using the CNS package (Brunger et al., 1998). Two selenium sites were
found in each crystal form using an automated Patterson heavy atom
search method and peak (P21 crystal form) or inflection (C2221 crystal
form) anomalous wavelength data. The additional two selenium sites for
the P21 crystal form were found using an anomalous difference Fourier
map and an experimental density modified map that used phases from the
two selenium sites found in the initial automated search. The coordinates
for these two additional selenium sites were refined using the CNS pack-
age and used for subsequent phase determination and map building.
MAD phasing used the selenium coordinates and the low energy remote
wavelength as reference. Phases were improved by solvent flipping and
histogram matching. Model building was done with O (Jones et al.,
1991). Refinement was preformed with the CNS package and monitored
with a random 10% of the data used for cross-validation. Model refine-
ment used the MLHL target function, torsion angle molecular dynamics
simulated annealing, B-factor refinement, and rebuilding in O with  A-
weighted difference Fourier maps. The C2221 crystal form structure refine-
ment was extended to the high resolution of the native data set using the
MLF target function. Figures were prepared with PyMOL (DeLano Scien-
tific) and GRASP (Nicholls et al., 1991). Coordinates have been depos-
ited in the Protein Data Bank under accession codes 1YIG (P21 crystal
form) and 1YIB (C2221 crystal form).
Surface plasmon resonance studies
Surface plasmon resonance experiments were conducted using a Biacore
1000 and Streptavidin sensor chips (Biacore). Flow cells were pretreated
with 2   1 min injections of 1 M NaCl, 50 mM NaOH, and 3   1 min in-
jections of regeneration solution (0.25% SDS). Flow cells were normalized
and one flow cell was injected with 50  l of 10  M H6-MACF21595-1637-
Biotinylation Tag protein at a 5  l/min flow rate to yield an increase of
600 response units. The second flow cell was used as a control surface
over which identical analyte injections were performed in triplicate. All
runs were conducted at a flow rate of 20  l/min in running buffer (10 mM
Tris, pH 8.0, 200 mM NaCl, 0.1%  -ME, and 0.05% Tween-20) at 25 C.
Sensor chips were prestabilized for 2 min with running buffer. Analyte
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ysis of dissociation. The sensor chip was regenerated by injection of
0.25% SDS for 1 min followed by a 5.5-min stabilization of running buffer
before the start of the next sensogram. For full-length EB1 analysis, eight
different concentrations of H6-EB1 were injected onto the sensor chip in
triplicate (2.4 nM, 10 nM, 39 nM, 160 nM, 630 nM, 2.5  M, 10  M,
and 40  M). Binding studies using wild-type and mutant EB1 proteins
were conducted at an analyte concentration of 2.5  M and conducted in
triplicate. Data was processed using BIAevaluation 3.2 RC1 software.
Control analyte runs were subtracted from corresponding analyte plus
MACF2 peptide runs and calibrated for comparison via baseline adjust-
ment before analyte injection.
Gel filtration assay
Full-length human EB1 and EB1 point mutants (F216A, Y217A, F218A,
K220A, I224A, and E225A) were diluted in running buffer (25 mM Tris,
pH 8.0, 200 mM NaCl, and 0.1%  -ME) to a final concentration of 32
 M. 100  l of each protein was injected onto a Superdex200 Tricorn an-
alytical gel filtration column (Amersham Biosciences) equilibrated in run-
ning buffer and analyzed at a flow rate of 0.3 ml/min, measuring the ab-
sorbance at 280 nm.
Online supplemental material
GFP-Shot in interphase S2 cells shows microtubule plus end localization
(Video 1). Frames for Video 1 were acquired at a rate of one frame per 5 s.
Online supplemental material is available at http://www.jcb.org/cgi/
content/full/jcb.200410114/DC1.
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